# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-092375
Filing Date
2020-08-10
Accepted
2020-08-10 07:04:07
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | plx-20200630x10q.htm iXBRL | 10-Q | 818075
2 | EXHIBIT 4.8 | plx-20200630xex4d8.htm | EX-4.8 | 69002
3 | EXHIBIT 4.9 | plx-20200630xex4d9.htm | EX-4.9 | 65182
4 | EXHIBIT 10.1 | plx-20200630xex10d1.htm | EX-10.1 | 137467
5 | EXHIBIT 31.1 | plx-20200630xex31d1.htm | EX-31.1 | 10010
6 | EXHIBIT 31.2 | plx-20200630xex31d2.htm | EX-31.2 | 10370
7 | EXHIBIT 32.1 | plx-20200630xex32d1.htm | EX-32.1 | 6070
8 | EXHIBIT 32.2 | plx-20200630xex32d2.htm | EX-32.2 | 6096
14 | GRAPHIC | plx-20200630x10q005.jpg | GRAPHIC | 71543
15 | GRAPHIC | plx-20200630x10q006.jpg | GRAPHIC | 86893
| Complete submission text file | 0001104659-20-092375.txt |  | 3547694

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | plx-20200630.xsd | EX-101.SCH | 25123
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | plx-20200630_cal.xml | EX-101.CAL | 30495
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | plx-20200630_def.xml | EX-101.DEF | 83559
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | plx-20200630_lab.xml | EX-101.LAB | 197910
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | plx-20200630_pre.xml | EX-101.PRE | 169664
16 | EXTRACTED XBRL INSTANCE DOCUMENT | plx-20200630x10q_htm.xml | XML | 295903

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 201087036
SIC: 2836 Biological Products, (No Diagnostic Substances)